Commission channels funds into health tech research and innovation under FP7
This article was originally published in Clinica
The European Commission is allocating Euro7.3bn ($8.8bn) to the "specific programme" for health under the Seventh Framework Programme for Research and Development (FP7). Emphasis will be put on "transitional research", turning basic discoveries into clinical application, as well as on supporting the development of:
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.